Loading clinical trials...
Loading clinical trials...
The purpose of this study is to evaluate the safety profile, tolerability, pharmacokinetics and pharmacodynamics of ascending single doses of BMS-866949 in healthy subjects.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Bristol-Myers Squibb
NCT06277661 · Postpartum Depression, Postpartum Anxiety, and more
NCT07360600 · Parents, Children With Disabilities, and more
NCT07088380 · Major Depressive Disorder, Treatment Resistant Depression
NCT06748209 · Treatment Resistant Major Depression
NCT05685368 · Race-related Stress, Depression, Anxiety, and more
Local Institution
Uppsala
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions